201 related articles for article (PubMed ID: 35355939)
21. Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda.
Izudi J; Tamwesigire IK; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100153. PubMed ID: 32123755
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
23. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, associated factors and rifampicin resistance pattern of pulmonary tuberculosis among HIV-positive patients attending antiretroviral treatment clinic at East Gojjam Zone, Ethiopia: An institution-based cross-sectional study.
Toru M; Baye A; Gebeyehu Z; Abebaw A; Reta A
J Clin Tuberc Other Mycobact Dis; 2022 Dec; 29():100336. PubMed ID: 36405997
[TBL] [Abstract][Full Text] [Related]
25. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
Wasihun AG; Dejene TA; Hailu GG
PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
[TBL] [Abstract][Full Text] [Related]
26. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
[TBL] [Abstract][Full Text] [Related]
27. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
[TBL] [Abstract][Full Text] [Related]
28. Imaging modalities for pulmonary tuberculosis in children: A systematic review.
Tonne EO; Fosbøl MØ; Poulsen A; Nygaard U; Højgaard L; Borgwardt L
Eur J Radiol Open; 2023; 10():100472. PubMed ID: 36624819
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
[TBL] [Abstract][Full Text] [Related]
31. Nationwide HIV-, MDR-TB survey in Japan and collaborative study in the Philippines.
Hattori T; Kobayashi N; Nagai H; Chagan-Yasutan H; Telan E; Solante MB
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S18-S19. PubMed ID: 28043540
[TBL] [Abstract][Full Text] [Related]
32. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Salaam-Dreyer Z; Streicher EM; Sirgel FA; Menardo F; Borrell S; Reinhard M; Doetsch A; Cudahy PGT; Mohr-Holland E; Daniels J; Dippenaar A; Nicol MP; Gagneux S; Warren RM; Cox H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0036421. PubMed ID: 34460307
[TBL] [Abstract][Full Text] [Related]
33. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.
Chamie G; Luetkemeyer A; Walusimbi-Nanteza M; Okwera A; Whalen CC; Mugerwa RD; Havlir DV; Charlebois ED
Int J Tuberc Lung Dis; 2010 Oct; 14(10):1295-302. PubMed ID: 20843421
[TBL] [Abstract][Full Text] [Related]
34. Detection of
Selfegna S; Alelign A
Tuberc Res Treat; 2022; 2022():1250404. PubMed ID: 35087689
[TBL] [Abstract][Full Text] [Related]
35. Chest radiographic findings of pulmonary tuberculosis in severely immunocompromised patients with the human immunodeficiency virus.
Kisembo HN; Boon SD; Davis JL; Okello R; Worodria W; Cattamanchi A; Huang L; Kawooya MG
Br J Radiol; 2012 Jun; 85(1014):e130-9. PubMed ID: 21976629
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of concurrent pulmonary and extrapulmonary tuberculosis in Uganda: a retrospective study.
Kyagulanyi E; Mirembe J; Nantaayi B; Nalukenge S; Mukasa D; Tamale J; Oriekot A; Kamya MR; Baluku JB
Ther Adv Infect Dis; 2022; 9():20499361221107304. PubMed ID: 35795170
[TBL] [Abstract][Full Text] [Related]
37. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mboowa G; Namaganda C; Ssengooba W
BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis.
Elbrolosy AM; El Helbawy RH; Mansour OM; Latif RA
BMC Microbiol; 2021 May; 21(1):144. PubMed ID: 33980173
[TBL] [Abstract][Full Text] [Related]
40. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
